These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2786645)

  • 21. [Omeprazole and misoprostol for NSAID-induced gastropathies: comparative efficiency of their short-term treatment].
    Karateev AE; Murav'ev IuV
    Klin Med (Mosk); 2001; 79(5):48-50. PubMed ID: 11510188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of NSAID-induced gastropathy.
    Zeidler H
    Clin Rheumatol; 1991 Dec; 10(4):369-73. PubMed ID: 1802489
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs].
    Steen KS; Lems WF; Dijkmans BA
    Ned Tijdschr Geneeskd; 1999 Aug; 143(32):1649-52. PubMed ID: 10494299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NSAID gastropathy. A new understanding.
    Roth SH
    Arch Intern Med; 1996 Aug 12-26; 156(15):1623-8. PubMed ID: 8694659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapy of non-steroidal antirheumatic drug-induced gastrointestinal lesions with misoprostol].
    Bach GL; Stock KP; Hüdepohl M
    Z Rheumatol; 1991; 50(3):175-80. PubMed ID: 1927064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of NSAID-gastropathy.
    Ardizzone S; Bianchi Porro G
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():33-6. PubMed ID: 9032581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Non-steroidal anti-inflammatory drug induced gastropathy and preventive effects of teprenone on the gastropathy in rats].
    Ma J; Yuan G; Chen MH
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2868-73. PubMed ID: 17200026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prophylaxis and treatment of NSAID-induced gastroduodenal disorders.
    La Corte R; Caselli M; Castellino G; Bajocchi G; Trotta F
    Drug Saf; 1999 Jun; 20(6):527-43. PubMed ID: 10392669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Options in the treatment and prevention of NSAID-induced gastroduodenal mucosal damage.
    Agrawal NM; Dajani EZ
    J Rheumatol Suppl; 1990 Feb; 20():7-11. PubMed ID: 1969964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylaxis and treatment of NSAID-induced gastropathy.
    Ament PW; Childers RS
    Am Fam Physician; 1997 Mar; 55(4):1323-6, 1331-2. PubMed ID: 9092293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention and treatment of nonsteroidal anti-inflammatory drug-induced gastropathy.
    Lee M
    South Med J; 1995 May; 88(5):507-13. PubMed ID: 7732438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recurrence of gastropathies caused by intake of nonsteroidal anti-inflammatory drugs].
    Karameev AE
    Ter Arkh; 2003; 75(5):74-8. PubMed ID: 12847904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New understandings of NSAID gastropathy.
    Roth SH
    Scand J Rheumatol Suppl; 1989; 78():24-9; discussion 30-2. PubMed ID: 2660252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of pantoprazol for treatment of gastroesophageal reflux disease and NSAID-induced gastropathy].
    Pakhomova IG
    Eksp Klin Gastroenterol; 2007; (6):110-5. PubMed ID: 18416104
    [No Abstract]   [Full Text] [Related]  

  • 35. Epidemiology and economics of NSAID-induced gastropathy.
    Zeidler H
    Scand J Rheumatol Suppl; 1992; 92():3-8. PubMed ID: 1574686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonsteroidal anti-inflammatory drug gastropathy.
    Laine L
    Gastrointest Endosc Clin N Am; 1996 Jul; 6(3):489-504. PubMed ID: 8803564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease.
    Joshua FF; Oakley SP; Major GA
    Intern Med J; 2004 Apr; 34(4):153-61. PubMed ID: 15086694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role of anti-ulcerative drugs in treatment and prevention of gastropathies induced by nonsteroidal anti-inflammatory drugs].
    Fialová P; Vlcek J
    Vnitr Lek; 2004 Nov; 50(11):858-66. PubMed ID: 15648967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sucrose permeability as a marker for NSAID-induced gastroduodenal injury.
    Erlacher L; Wyatt J; Pflugbeil S; Köller M; Ullrich R; Vogelsang H; Smolen JS; Graninger W
    Clin Exp Rheumatol; 1998; 16(1):69-71. PubMed ID: 9543566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.